COLDUNELL LIMITED

1. Financial Health Score: B+

Explanation: COLDUNELL LIMITED is like a mature, robust patient with a strong constitution but currently experiencing a minor fever due to market conditions. The company possesses a very strong balance sheet with substantial net assets and excellent short-term liquidity. However, the recent significant write-down in investment property values has caused a noticeable contraction in overall equity, preventing a higher score. The patient is in no immediate danger, but the underlying market conditions require monitoring.

2. Key Vital Signs

• Net Asset Strength (Bone Density): £52.6M The company’s "bone density" is exceptionally strong. With net assets of over £52.6 million, the business has a substantial equity foundation. However, this is down from £58M in 2024 and a peak of £62.2M in 2023, indicating some loss of skeletal strength due to asset revaluations rather than operational failure.

• Liquidity / Current Ratio (Blood Flow): 8.4x Current assets (£15.7M) vastly exceed current liabilities (£1.9M). This indicates extremely healthy "blood flow," meaning the company can comfortably meet its short-term obligations without breaking a sweat. There are no signs of short-term financial asphyxiation.

• Cash Reserves (Hydration): £979,468 Cash levels have stabilized around the £1M mark, recovering slightly from £856k in 2024. While this is a healthy level for operational needs, it is notably lower than the £4.6M peak in 2021, suggesting the company has been deploying cash or distributing dividends, but remains adequately hydrated.

• Long-Term Liabilities (Cholesterol): £33.8M Long-term creditors have increased from zero in 2024 to £33.8M in 2025. This is a significant structural change to the heart of the balance sheet. While typical for property companies utilizing mortgage finance, this debt load requires steady rental income to service. Alongside the £4.8M in provisions, this represents a heavy load for the patient to carry over the long term.

3. Diagnosis

Symptoms Analysis: The primary symptom presenting in the 2025 accounts is a £9M write-down in Investment Property values (falling from £86M to £77.1M). This fair value adjustment is the direct cause of the £5.4M drop in the Profit and Loss reserve (from £57.9M to £52.5M). The underlying business model—leasing real estate—remains intact, but the asset portfolio has caught a "market chill," reflecting current downward pressures on commercial or residential property valuations in the UK.

Additionally, the sudden appearance of £33.8M in long-term creditors (compared to £0 the previous year) suggests the company has recently taken on significant long-term debt or restructured existing borrowings. Given the property-heavy balance sheet, this is likely secured against the investment properties.

Overall Diagnosis: The patient suffers from Market-Induced Asset Deflation coupled with Leveraged Restructuring. The core operational health (liquidity and asset backing) is sound. The company is not insolvent or distressed; rather, it is experiencing the natural cyclical fluctuations of the real estate market. The shift in liabilities from current to long-term actually improves the immediate liquidity picture, replacing what was likely a short-term facility with long-term financing, which is generally a healthier financing structure for property assets.

4. Recommendations

To maintain and improve financial wellness, the following "prescriptions" are recommended:

• Monitor the "Cholesterol" (Debt Servicing): With £33.8M now in long-term debt, it is critical to ensure that the rental income (the company's metabolism) comfortably covers the interest payments. Regular stress-testing of cash flows against potential interest rate rises is essential.
• Maintain Cash Hydration: While current cash levels are adequate, the trend from £4.6M to under £1M over four years suggests significant cash deployment. Maintaining a minimum cash buffer equal to 6-12 months of operational and interest expenses will guard against unexpected market shocks.
• Review Asset Vitality: The £9M property devaluation should be investigated. Management should assess whether this is a general market symptom or specific to properties in the portfolio. Consider disposing of underperforming assets to streamline the portfolio.
• Provision Check-up: The £4.8M in provisions should be reviewed to ensure the anticipated expenses (likely property dilapidation or lease incentives) are accurately estimated and not over-provisioned, which unnecessarily obscures the true equity position.